Dendritic Cell Based Therapy of Cancer

[1]  B. Pulendran,et al.  Administration of FLT3 ligand results in the generation of large numbers of phenotypically distinct populations of dendritic cells in mice , 1996 .

[2]  Simon C Watkins,et al.  Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. , 1996, Journal of immunology.

[3]  L. Zitvogel,et al.  IL‐12‐Engineered Dendritic Cells Serve as Effective Tumor Vaccine Adjuvants in Vivo a , 1996, Annals of the New York Academy of Sciences.

[4]  H. Sakamoto,et al.  Therapy of murine tumors with p53 wild-type and mutant sequence peptide- based vaccines , 1996, The Journal of experimental medicine.

[5]  M. Colombo,et al.  Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo , 1996, The Journal of experimental medicine.

[6]  J. Mayordomo,et al.  Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity , 1996, The Journal of experimental medicine.

[7]  K. Inaba,et al.  Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity , 1996, The Journal of experimental medicine.

[8]  L. Zitvogel,et al.  Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines , 1996, The Journal of experimental medicine.

[9]  L. Zitvogel,et al.  Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity , 1995, Nature Medicine.

[10]  C. Figdor,et al.  Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. , 1995, Cancer research.

[11]  D. Taub,et al.  CD28:B7 interactions promote T cell adhesion , 1995, European journal of immunology.

[12]  J. Banchereau,et al.  Functional expression of CD40 antigen on human epidermal Langerhans cells. , 1995, Journal of immunology.

[13]  Liangji Zhou,et al.  A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. , 1995, Blood.

[14]  A. Galy,et al.  Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. , 1995, Immunity.

[15]  P. Srivastava,et al.  A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. , 1995, Science.

[16]  O. de Backer,et al.  A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma , 1995, The Journal of experimental medicine.

[17]  H. Rammensee,et al.  Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96 , 1995, The Journal of experimental medicine.

[18]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[19]  E. Gilboa,et al.  Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes , 1995, The Journal of experimental medicine.

[20]  M. Moore,et al.  Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. , 1995, Journal of immunology.

[21]  H. Dienes,et al.  Uptake of microparticle‐adsorbed protein antigen by bone marrow‐derived dendritic cells results in up‐regulation of interleukin‐1α and interleukin‐12 p40/p35 and triggers prolonged, efficient antigen presentation , 1995, European journal of immunology.

[22]  S. Tsujitani,et al.  Infiltration of dendritic cells into regional lymph nodes in gastric cancer , 1995, Cancer.

[23]  G. Schaumburg‐Lever,et al.  Langerhans' cells in skin tumors. , 1995, Archives of dermatology.

[24]  H. Muller,et al.  Tobacco smoke condensate cutaneous carcinogenesis: changes in Langerhans' cells and tumour regression. , 1995, International journal of experimental pathology.

[25]  S. Rosenberg,et al.  Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes [published erratum appears in J Exp Med 1995 Mar 1;181(3):1261] , 1995, The Journal of experimental medicine.

[26]  R. Brasseur,et al.  BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. , 1995, Immunity.

[27]  E. V. van Rensburg,et al.  Lack of correlation between DNA ploidy, Langerhans cell population and grading in oral squamous cell carcinoma. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[28]  M. Lotze,et al.  Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes , 1995, The Journal of experimental medicine.

[29]  P. Coulie,et al.  A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3 , 1994, European journal of immunology.

[30]  R. Steinman,et al.  The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro , 1994, The Journal of experimental medicine.

[31]  P. Bruggen,et al.  Autologous cytolytic T lymphocytes recognize a MAGE‐1 nonapeptide on melanomas expressing HLA‐Cw* 1601 , 1994, European journal of immunology.

[32]  K. Sakaguchi,et al.  Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Steinman,et al.  Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.

[34]  J. Renauld,et al.  A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1994, The Journal of experimental medicine.

[35]  S. Girod,et al.  Langerhans cells in epithelial tumors and benign lesions of the oropharynx. , 1994, In Vivo.

[36]  A. Srivastava,et al.  Phenotype, genotype and cytokine production in acute leukemia involving progenitors of dendritic Langerhans' cells. , 1994, Leukemia research.

[37]  S. Rosenberg,et al.  Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. , 1994, Cancer research.

[38]  G. Schuler,et al.  Understanding the dendritic cell lineage through a study of cytokine receptors , 1994, The Journal of experimental medicine.

[39]  C. Fellbaum,et al.  Follicular dendritic cells have prognostic relevance in Hodgkin's disease. , 1994, American journal of clinical pathology.

[40]  F. Tacchini-Cottier,et al.  Exposure of monocytes to heat shock does not increase class II expression but modulates antigen-dependent T cell responses. , 1994, International immunology.

[41]  P. Srivastava,et al.  Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. , 1994, Journal of immunology.

[42]  R. Henderson,et al.  Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.

[43]  S. Rosenberg,et al.  Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Srivastava,et al.  Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[46]  D. Schmitt,et al.  TNF alpha expressing cells in epidermal tumors: correlation with ICAM-1 induction on keratinocytes and Langerhans cell distribution. , 1994, In Vivo.

[47]  M. Moser,et al.  Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo , 1994, European journal of immunology.

[48]  P. Romero,et al.  Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes , 1994, The Journal of experimental medicine.

[49]  C. Figdor,et al.  Melanocyte lineage-specific antigen gp100 is recognized by melanoma- derived tumor-infiltrating lymphocytes , 1994, The Journal of experimental medicine.

[50]  B. Seliger,et al.  Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes , 1994, European journal of immunology.

[51]  J. Chan,et al.  Follicular Dendritic Cell Tumors of the Oral Cavity , 1994, The American journal of surgical pathology.

[52]  P. Srivastava,et al.  Heat shock protein 70-associated peptides elicit specific cancer immunity , 1993, The Journal of experimental medicine.

[53]  Z. Li,et al.  Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. , 1993, The EMBO journal.

[54]  A. Nussler,et al.  Inflammation, immunoregulation, and inducible nitric oxide synthase , 1993, Journal of leukocyte biology.

[55]  P. Coulie,et al.  The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1993, The Journal of experimental medicine.

[56]  M. Yamakawa,et al.  Dendritic cells in esophageal cancer and lymph node tissues. , 1993, In vivo.

[57]  J. Smolle,et al.  Langerhans cells in epithelial skin tumors. A quantitative immunohistological and morphometric investigation. , 1993, In Vivo.

[58]  Y. Becker.  Dendritic cell activity against primary tumors: an overview. , 1993, In vivo.

[59]  Austyn Jm.  The dendritic cell system and anti-tumour immunity. , 1993 .

[60]  T. Löning,et al.  Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome. , 1993, In vivo.

[61]  I. I. Kessler.  Epidemiological considerations in the role of dendritic/Langerhans cells in human cancer. , 1993, In Vivo.

[62]  Y. Karube,et al.  Dendritic cells in various human thyroid diseases. , 1993, In vivo.

[63]  H. Muller,et al.  Langerhans cell alterations in cutaneous carcinogenesis. , 1993, In vivo.

[64]  E. V. van Rensburg,et al.  Langerhans cells and human papillomaviruses in oesophageal and laryngeal carcinomas. , 1993, In vivo.

[65]  Y. Maehara,et al.  Dendritic cells prevent lymph node metastasis in patients with gastric cancer. , 1993, In vivo.

[66]  M. Herlyn,et al.  Melanoma cells and normal melanocytes share antigens recognized by HLA- A2-restricted cytotoxic T cell clones from melanoma patients , 1993, The Journal of experimental medicine.

[67]  S. Smith,et al.  Identification of potent mixed leukocyte reaction-stimulatory cells in human bone marrow. Putative differentiation stage of human blood dendritic cells. , 1993, Journal of immunology.

[68]  R. Morimoto,et al.  Cells in stress: transcriptional activation of heat shock genes. , 1993, Science.

[69]  A. Cochran,et al.  Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. , 1993, The Journal of investigative dermatology.

[70]  R. Gupta,et al.  Human peripheral gamma delta T cells recognize hsp60 molecules on Daudi Burkitt's lymphoma cells. , 1993, Journal of immunology.

[71]  R. Zappatore,et al.  Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection. , 1993, Gynecologic oncology.

[72]  J. Yewdell,et al.  Identification of human cancers deficient in antigen processing , 1993, The Journal of experimental medicine.

[73]  A. Morelli,et al.  Relationship between types of human papillomavirus and Langerhans' cells in cervical condyloma and intraepithelial neoplasia. , 1993, American journal of clinical pathology.

[74]  P. Soler,et al.  Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. , 1993, The Journal of clinical investigation.

[75]  S. Tonegawa,et al.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells , 1992, Cell.

[76]  Takeo Takahashi,et al.  Roles of langerhans' cells and T‐lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer , 1992, Cancer.

[77]  M. Lindberg,et al.  Density and morphology of Langerhans cells in basal cell carcinomas of the face and trunk , 1992, The British journal of dermatology.

[78]  C. Papadimitriou,et al.  Langerhans cells and lymphocyte subsets in human gastrointestinal carcinomas. An immunohistological study on frozen sections. , 1992, Pathology, research and practice.

[79]  Catia,et al.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E , 1992, The Journal of experimental medicine.

[80]  D. Fivenson,et al.  Dermal dendrocytes and T‐cells in canine mycosis fungoides. Support for an animal model of human cutaneous T‐cell lymphoma , 1992, Cancer.

[81]  Y. Maehara,et al.  Infiltration of S-100 protein positive dendritic cells and peritoneal recurrence in advanced gastric cancer. , 1992, International surgery.

[82]  J. Regezi,et al.  Oral submucosal dendrocytes: factor XIIIa+ and CD34+ dendritic cell populations in normal tissue and fibrovascular lesions , 1992, Journal of cutaneous pathology.

[83]  D. Kumar,et al.  Dendrocyte Population in Cutaneous and Extracutaneous Kaposi's Sarcoma , 1992, The American Journal of dermatopathology.

[84]  R. Steinman,et al.  Identification of proliferating dendritic cell precursors in mouse blood , 1992, The Journal of experimental medicine.

[85]  A. Morelli,et al.  Assessment by planimetry of Langerhans' cell density in penile epithelium with human papillomavirus infection: changes observed after topical treatment. , 1992, The Journal of urology.

[86]  A. Cochran,et al.  Effect of epidermal Langerhans cells from melanoma patients on lymphoproliferative responses , 1992, Melanoma research.

[87]  V. Ernster,et al.  Reduction of Langerhans cells in smokeless tobacco-associated oral mucosal lesions. , 1992, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[88]  V. Devita,et al.  Biologic Therapy of Cancer , 1992 .

[89]  P. Chomez,et al.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.

[90]  O. Gallo,et al.  Langerhans cells related to prognosis in patients with laryngeal carcinoma. , 1991, Archives of otolaryngology--head & neck surgery.

[91]  G. Halliday,et al.  Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. , 1991, The Journal of investigative dermatology.

[92]  R. Gallo,et al.  Tumor antigen presentation by murine epidermal cells. , 1991, Journal of immunology.

[93]  M. Gómez-Morales,et al.  Diffuse sclerosing papillary carcinoma of the thyroid gland: immunohistochemical analysis of the local host immune response , 1991, Histopathology.

[94]  S. Bianchi,et al.  Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance , 1991, The Laryngoscope.

[95]  L. Messerini,et al.  Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma. , 1991, Pathology, research and practice.

[96]  D. Jenkins,et al.  CD 1a and S100 antigen expression in skin Langerhans cells in patients with breast cancer , 1991 .

[97]  E. Margoliash,et al.  A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family , 1989, The Journal of experimental medicine.

[98]  G. Koch,et al.  Perturbation of cellular calcium induces secretion of luminal ER proteins , 1989, Cell.

[99]  R. Willemze,et al.  Inhibition of human macrophage colony formation by interleukin 4 , 1989, The Journal of experimental medicine.

[100]  K. Nocka,et al.  Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor. , 1988, Journal of immunology.

[101]  R. Mazzarella,et al.  ERp99, an abundant, conserved glycoprotein of the endoplasmic reticulum, is homologous to the 90-kDa heat shock protein (hsp90) and the 94-kDa glucose regulated protein (GRP94). , 1987, The Journal of biological chemistry.

[102]  C. Doré,et al.  Influence of dendritic cells on tumor growth. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[103]  E. Unanue,et al.  Prostaglandins modulate macrophage Ia expression , 1982, Nature.

[104]  Edgar G. Engleman,et al.  Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells , 1996, Nature Medicine.

[105]  K. Koretz,et al.  Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells. , 1993, European journal of cancer.

[106]  S. Rosenberg,et al.  Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines. , 1993, Cancer research.

[107]  H. Drexhage,et al.  Dendritic cells in tumor growth and endocrine diseases. , 1993, Advances in experimental medicine and biology.

[108]  Naiem A. Zeid,et al.  S 100 Positive Dendritic Cells In Human Lung Tumors Associated With Cell Differentiation And Enhanced Survival , 1993, Pathology.

[109]  C. Georgopoulos,et al.  Role of the major heat shock proteins as molecular chaperones. , 1993, Annual review of cell biology.

[110]  P. Barbini,et al.  Bronchiolo-alveolar carcinoma: an analysis of survival predictors. , 1992, European journal of cancer.

[111]  Y. Maehara,et al.  Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer. , 1992, Anticancer research.

[112]  M. Furihata,et al.  HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma— Their distribution in relation to prognosis , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

[113]  B. Polla,,et al.  More evidence for a case for chaperones in antigen processing. , 1992, Immunology today.

[114]  D. Bani,et al.  Interdigitating cells in the peritumoral infiltrate of laryngeal carcinomas: an immunocytochemical and ultrastructural study. , 1991, ORL; journal for oto-rhino-laryngology and its related specialties.

[115]  A. Coli,et al.  Distribution of langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological grade , 1991, The Prostate.

[116]  L. Pelus,et al.  In vivo modulation of myelopoiesis by prostaglandin E2. II. Inhibition of granulocyte-monocyte progenitor cell (CFU-GM) cell-cycle rate. , 1987, Experimental hematology.